Studi clinici su BPCO nello stato di South Carolina
14 studi su BPCO cercano partecipanti presso sedi nello stato di South Carolina.
Città nello stato di South Carolina
Testo ufficiale dello studio (inglese)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Anderson
- Research Site, Charleston
- Research Site, Gaffney
- e altri 2
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- MedTrial- Site Number : 8400010, Columbia
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research of Rock Hill, Rock Hill
In reclutamentoFase 2
Età da 40 a 85 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- AnMed Oglesby Center- Site Number : 8400074, Anderson
- MD First Research - Lancaster- Site Number : 8400102, Lancaster
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Lancaster
- Research Site, Spartanburg
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Anderson
- Research Site, Columbia
- Research Site, Gaffney
- e altri 2
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Rock Hill
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Bogan Sleep Consultants, LLC, Columbia
- Velocity Clinical Research, Gaffney, Gaffney
- Clinical Research of Rock Hill, Rock Hill
- e altri 1
In reclutamentoFase 2/3
Età da 35 a 80 · Tutti i sessi · Aggiornato il 31 ago 2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
In reclutamentoFase 3
Età da 18 a 80 · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT07555483STRIVE Post-Market Registry Study
- AnMed Health, Anderson
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Greenville
- GSK Investigational Site, Rock Hill
In reclutamentoFase 3
Età da 40 a 75 · Tutti i sessi · Aggiornato il 28 lug 2026 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Spartanburg
- GSK Investigational Site, Union
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 9 apr 2026 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Rock Hill
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 8 ott 2025 · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Medical University of South Carolina (MUSC), Charleston
- McLeod Health, Florence
In reclutamentoStudio osservazionale
Età 50 e oltre · Tutti i sessi · Aggiornato il 5 ago 2025 · NCT06122077Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.